1. Shanahan F. Crohn's disease. Lancet 2002;359:62-69.
2. Ballinger AB, El-Haj, Perrett D, et al. The role of medial hypothalamic serotonin in the suppression of feeding in a rat model of colitis. Gastroenterol 2000;118:544-553.
3. Shintani F, Kanba S, Nakaki T, et al. Interleukin-1 augments the release of norepinephrine, dopamine, and serotonin in the rat hypothalamus. J Neurosci 1993;13:3574-3581.
5. MacDermott RP. Alterations of the immune system in inflammatory bowel disease. J Gastroenterol 1996;31:907-916.
6. Sartor RH. Pathogenesis and immune mechanisms of chronic inflammatory bowel diseases. Am J Gastroenterol 1997;92:5S-11S.
7. Bannerman E, Davidson I, Conway C, et al. Altered subjective appetite parameters in Crohn's disease patients. Clin Nutr 2001;20:399-405.
8. Jowett SL, Seal CJ, Phillips E, et al. Dietary beliefs of people with ulcerative colitis and their effect on relapse and nutrient intake. Clin Nutr 2004;23:161-170.
9. Mahida YR, Kurlac L, Hawkey CF. High circulating concentrations of interleukin-6 in active Crohn's disease but not ulcerative colitis. Gut 1991;32:1531-1534.
10. Reimund JM, Duclos B, Sapin, et al. Systemic tumor necrosis factor in Crohn's disease; relationship to disease activity and circulating acute phase reactants. Eur J Gastroenterol Hepatol 1992;4:919-923.
11. Reimund JM, Wittersheim C, Dumont S, et al. Mucosal inflammatory cytokine production by intestinal biopsies. J Clin Immunol 1996;16:144-150.
12. Schreiber S, Nikolaus S, Hampe J, et al. Tumour necrosis factor a and interleukin 1ß in relapse of Crohn's disease. Lancet 1999;353:459-461.
13. Reimund RM, Arondel Y, Escalin G, et al. Immune activation and nutritional status in adult Crohn's disease patients. Dig Liver Dis 2005;37:424-431.
14. Perlmutter DH, Dinarello CA, Punsai PI, Colten HR. Chactin/tumor necrosis factor regulates hepatic acute phase gene expression. J Clin Invest 1986;78:1349-1354.
15. Stokes MA, Hill GL. Total energy expenditure in patients with Crohn's disease: Measurement by the combined body scan technique. JPEN J Parenter Enteral Nutr 1993;17:3-7.
16. Chan ATH, Fleming CR, O'Fallon WM, et al. Estimated versus measured basal energy requirements in patients with Crohn's disease. Gastroenterology 1986;91:75-78.
17. Al-Jaouni R, Hebuterne X, Pouget I, et al. Energy metabolism and substrate oxidation in patients with Crohn's disease. Nutrition 2000;16:173-178.
18. Mingrone G, Capristo E, Greco AV, et al. Elevated diet-induced thermogenesis and lipid oxidation rate in Crohn's disease. Am J Clin Nutr 1999;69:325-330.
19. Reif S, Klein I, Lubin F, et al. Pre-illness dietary factors in inflammatory bowel disease. Gut 1997;40:754-760.
20. Gassull MA, Cabré E. Nutrition in inflammatory bowel disease. Curr Opin Clin Nutr Metabol Care 2001;4:561-569.
21. Segain JP, Raingaard de la Bletiere D, Bourrelle A, et al. Butyrate inhibits inflammatory response through NFk B inhibition: implications for Crohn's disease. Gut 2000;47:397-403.
22. Kromann N, Green A. Epidemiological studies in Upernavik district, Greenland. Act Med Scand 1980;208:401-406.
23. Bang H, Dyerberg J, Hjorne N. The composition of food consumed by Greenland Eskimos. Acta Med Scand 1976;200:69-73.
24. Meydani SN. Effect of (n-3) polyunsaturated fatty acids on cytokine production and their biologic function. Nutrition 1996;12(Suppl 1);S8-S14.
25. Grimble RF. Nutritional modulation of cytokine biology. Nutrition 1998;14:634-640.
26. Geerling BJ, Dagnellie PC, Badart-Smook A, et al. Diet as a risk factor for the development of ulcerative colitis. Am J Gastroenterol 2000;95:1008-1013.
27. Crohn BB, Ginzburg L, Oppenheimer GD. Regional ileitis. A pathologic and clinical entity. J Am Med Assoc 1932,99;1323-1329.
28. Stokes MA. Crohn's disease and nutrition. Br J Surg 1992,79: 391-394.
29. Kleinman RE, Baldassano RN, Caplan A, et al. Nutrition support for pediatric patients with inflammatory bowel disease. J Pediatr Gastrol Nutr 2004:39:15-27.
30. Fernández Bañares F, Abad Lacruz A, Xiol X, et al. Vitamin status in patients with inflammatory bowel disease. Am J Gastroenterol 1989; 84:744-746.
31. Kuroki F, Iida M, Tominaga M, et al. Multiple vitamin status in Crohn's disease. Correlation with disease activity. Dig Dis Sci 1993;98:1614-1618.
32. Geerling BJ, Badart-Smook A,Stockbruegger RW, et al. Comprehensive nutritional status in patients with long-standing Crohn's disease currently in remission. Am J Clin Nutr 1998;67:919-926.
33. Bouevaros A, Zurskowski D, Duggan C, et al. Vitamins A and E serum levels in children and young adults with inflammatory bowel disease: effect of disease activity. J Pediatr Gastroenterol Nutr 1998;26:129-134.
34. Reimund JM, Hirth C, Koehl C, et al. Antioxidant and immune status in active Crohn's disease. A possible relationship. Clin Nutr 2000;19:43-48.
35. Siffledeen JS, Siminoski K, Steinhart H, et al. The frequency of vitamin D deficiency in adults with Crohn's disease. Can J Gastroenterol 2003;17:473-478.
36. Klaus J, Armbrecht G, Steinkamp M, et al. High prevalence of osteoporotic vertebral fractures in patients with Crohn's disease. Gut 2002;51:654-658.
37. Hebetzion A, Silverberg MS, Parkes R, et al. Risk factors for low bone density in Crohn's disease. Inflamm Bowel Dis 2002;8:87-92.
38. Deer KL, Compston JE, Hunter JO. Treatments for Crohn's disease that minimize steroid doses are associated with a reduced risk of osteoporosis. Clin Nutr 2001;20:541-546.
39. de Jong DJ, Corstens FH, Mannaerts L, et al. Corticosteroid-induced osteoporosis: does it occur in patients with Crohn's disease? Am J Gastroenterol 2002;97:2011-2015.
40. Geerling BJ, Bardart-Smook A, Stockbrügger RW et al. Comprehensive nutritional status in recently diagnosed patients with inflammatory bowel disease compared with population controls. Eur J Clin Nutr 2000;54:514-521.
41. Kuzminski AM, Del Giacco FJ, Allen RH, et al. Effective treatment of cobalamin deficiency with oral cobalamin. Blood 1998;92:1191-1198.
42. Chowers Y, Sela BA, Holland R, et al. Increased levels of homocysteine in patients with Crohn's disease are related to folate levels. Am J Gastroenterol 2000;95:3498-3502.
43. den Heijer M, Koster T, Blom HJ, et al. Hyperhomocysteinemia as a risk factor for deep-vein thrombosis. N Engl J Med 1996;334:759-762.
44. Nygard O, Nordrehaug JE, Refsum H, et al. Plasma homocysteine levels and mortality in patients with coronary artery disease. N Engl J Med 1997; 337:230-236.
45. Lashner BA, Provencher KS, Seidner DL, et al. The effect of folic acid supplementation on risk of cancer or dysplasia in ulcerative colitis. Gastroenterol 1997;112:29-32.
46. Gassull MA. The role of nutrition in the treatment of inflammatory bowel disease. Aliment Pharmacol Ther 2004;20 (Suppl):79-83.
47. Miralles-Barrachina O, Savoye G, Belmonte-Zalar L, et al. Low levels of glutathione in endoscopic biopsies of patients with Crohn's colitis: the role of malnutrition. Clin Nutr 1999;18:313-317
48. Fernández Bañares F. Role of reactive oxygen metabolites in the pathogenesis of chronic inflammatory bowel disease. Gastroenterol Hepatol 1995:526-532.
49. Muller J M, Keller H W, Erasmus H, et al. Total parenteral nutrition as the sole therapy in Crohn's disease: A prospective study. Br J Surg 1983;70:40-43.
50. Greenberg, GR, Fleming, CR, Jeejeebhoy, JN, et al. Controlled trial of bowel rest and nutrition support in the management of Crohn's disease. Gut 1988;29;1309-1315.
51. Voitk AJ, Echave V, Feller JH, et al. Experience with elemental diet in the treatment of inflammatory bowel disease. Is this primary therapy? Arch Surg 1973;107:329-333.
52. O'Moráin C, Segal AW, Levi AJ. Elemental diet as primary treatment of acute Crohn's disease: a controlled trial. Br Med J 1984;288:1859-1862.
53. Walker-Smith JA. Therapy of Crohn's disease in childhood. Baillieres Clin Gastroenterol 1997;11:593-610.
54. Griffiths AM. Enteral nutrition: The neglected primary therapy of active Crohn's disease. J Pediatr Gastroenterol Nutr 2000;31:8-15.
55. Verma S, Kirkwood B, Brown S, et al. Oral nutritional supplementation is effective in the maintenance of remission in Crohn's disease. Digest Liver Dis 2000;32:769-774.
56. Verma S, Holdsworth CD, Giaffer MH. Does adjuvant nutritional support diminish steroid dependency in Crohn disease? Scan J Gastroenterol 2001; 36:383-388.
57. Fernández Bañares F, Cabré E, Esteve Comas M, et al. How effective is enteral nutrition in inducing remission in active Crohn's disease? A meta-analysis of the randomized clinical trials. JPEN J Parenter Enteral Nutr 1995;19:356-364.
58. Griffiths AM, Ohlsson A, Sherman PM, et al. Meta-analysis of enteral nutrition as a primary treatment of active Crohn's disease. Gastroenterol 1995;108:1056-1067.
59. Messori A, Trallori G, D'Albasio G, et al. Defined-formula diets versus steroids in the treatment of active Crohn's disease: a meta-analysis. Scand J Gastroenterol 1996;31:267-272.
60. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for inducing remission of Crohn's disease. Cochrane Database Syst Rev 2001: Issue 3.
61. Zachos M, Tondeur M, Griffiths AM. Enteral nutritional therapy for induction of remission in Crohn's disease. Cochrane Database Syst Rev 2005;Vol 4.
62. Griffiths AM. Enteral nutrition in the management of Crohn's disease. JPEN J Parenter Enteral Nutr 2005;29 (Suppl):S108-S112.
63. Heuschkel RB, Menache CC, Megerian JT, et al. Enteral nutrition and corticosteroids in treatment of acute Crohn's disease in children: a meta-analysis and review of the literature. J Pediatr Gastroenterol Nutr 2000;31;8-15.
64. Ludvigsson JF, Krantz M, Bodin L, et al. Elemental versus polymeric enteral nutrition in paediatric Crohn's disease: a multicentre randomized controlled trial. 2004: 93;327-335.
65. Knight C, El-Matary W, Spray C, et al. Long-term outcome of nutritional therapy in paediatric Crohn's disease. Clin Nutr 2005; 24:775-779.
66. Afzal NA, Davids S, Paintin M, et al. Colonic Crohn's disease in children does not respond well to treatment with enteral nutrition if the ileum is not involved. Dig Dis Sci 2005;50:1471-1475.
67. Afzal NA, van der Zaag-Loonen HJ, Arnaud-battaandier F, et al. Improvement in quality of life of children with acute Crohn's disease does not parallel mucosal healing after treatment with exclusive enteral nutrition. Aliment Pharmacol Ther 2004;20:167-172.
68. Nestle Nutrition. Proceedings from the workshop: Use of nutrition in the management and treatment of inflammatory bowel disease. JPEN J Parenter Enteral Nutr 2005; 29 (Suppl):S112-S113.
69. Williams JK, Higgs GA. Eicosanoids and inflammation. J Patrol 1988;156: 101-110.
70. Empery LR, Jewell LD, Gag ML, et al. Fish oil-enriched diet is mucosal protective against acetic acid-induced colitis in rats. Can J Physiol Pharmacol 1991;69:480-487.
71. Marta F, Chui DH, Saran P, et al. Shark fin enriched diet prevents mucosal lipid abnormalities in experimental acute colitis. Digestion 1995;56:46-51.
72. González-Huix F, de León, Fernández-Bañares F, et al. Polymeric enteral diets as primary treatment of active Crohn's disease: a prospective steroid controlled trial. Gut 1993;34:778-782.
73. Gassull MA, Fernández-Bañares F, Cabré E, et al. Fat composition may be a clue to explain the primary therapeutic effect of enteral nutrition in Crohn's disease: results of a double blind randomised multicentre European trial. Gut 2002;51:164-168.
74. Gorard DA. Enteral nutrition in Crohn's disease: fat in the formula. Eur J Gastroenterol Hepatol 2003;15:115-118.
75. Reimund J-M, Scheer O, Muller CD, et al. In vitro modulation of inflammatory cytokine production by three lipid emulsions with different fatty acid compositions. Clin Nutr 2004;23:1324-1332.
76. Bamba T, Shimoyamab T, Sasakiaa M, et al. Dietary fat attenuates the benefits of an elemental diet in active Crohn's disease: a randomized, controlled trial. Eur J Gastroenterol Hepatol 2003;15:151-157.
77. Yamamoto T, Nakahigashi M, Umegae S, et al. Impact of elemental diet on mucosal inflammation in patients with active Crohn's disease: cytokine production and endoscopic and histological findings. Inflamm Bowel Dis 2005;11:580-588.
78. Miura S, Tsuzuki Y, Hokari R, et al. Modulation of intestinal immune system by dietary fat intake: relevance to Crohn's disease. J Gastroenterol Hepatol 1998;15:151-157.
79. Forbes A. Crohn's disease—the role of nutritional therapy. Aliment Pharmacol Ther 2002;16 (Suppl 4):48-52.
80. Shoda R, Matsueda K, Yamada S, et al. Epidemiological analysis of Crohn's disease in Japan: increased dietary intake of w-6 polyunsaturated fatty acids and animal protein relates to the increased incidence of Crohn's disease in Japan. Am J Clin Nutr 1996;63:741-745.
81. Middleton SJ, Rucker JT, Kirby GA, et al. Long-chain triglycerides reduce the efficacy of enteral feeds in patients with active Crohn's disease. Clin Nutr 1995;14:229-236.
82. Geerling BJ, Badart-Smook A, van Deursen C, et al. Nutritional supplementation with N-3 fatty acids and antioxidants in patients with Crohn's disease in remission: effects on antioxidant status and fatty acid profile. Inflamm Bowel Dis 2000;6:77-84.
83. Belluzzi A, Brignola C, Campiere M, et al. Effect of an enteric-coated fish-oil preparation on relapse in inflammatory bowel disease. N Engl J Med 1996;334:1557-1560.
84. Lorenz-Meyer H, Bauer P, Nicolay C, et al. Omega-3 fatty acids and low carbohydrate diet for maintenance of remission in Crohn's disease. A randomized controlled multi-centre trial. Study Group Members (German Crohn's Disease Study Group. Scand J Gastroenterol 1996;31:778-785.
85. Asian A, Triadafilopoulos G. Fish oil fatty acid supplementation in active ulcer-ative colitis: a double-blind, placebo-controlled, crossover study. Am J Gastroen-terol 1992;87:432-437.
86. Middleton SJ, Naylor S, Woolner J, et al. A double-blind, randomized placebo-controlled trial of essential fatty acid supplementation in the maintenance of remission of ulcerative colitis. Aliment Pharmacol Ther 2002;16:1131-1135.
87. Evans JP, Steinhart AH, Cohen Z, et al. Home total parenteral nutrition: an alternative to early surgery for complicated inflammatory bowel disease. J Gastrointestinal Surg 2003;7:562-566.
88. Beattie RM. Enteral nutrition as primary therapy in childhood Crohn's disease: control of intestinal inflammation and anabolic response. JPEN J Parenter Enteral Nutr 2005;29 (Suppl):S151-S155.
89. Cezard JP, Touati G, Alberti C, et al. Growth in paediatric Crohn's disease. Horm Res 2002;58(Suppl 1):11-15.
90. Katz S, Pescovitz OH, Grosfeld JL. Growth failure and decreased levels of insulin-like growth factor I in obstructive jaundice are reversed by bile diversion. J Pediatr Surg 1991;26:900-902.
91. Thomas AG, Holly JM, Taylor F, et al. Insulin-like growth factor-I, insulin-like growth factor binding protein-I, and insulin in childhood Crohn's disease. Gut 1993;34:944-947.
92. Murch SH, Lamkin VA, Savage MO, et al. Serum concentrations of tumour necrosis factor-alpha in childhood chronic inflammatory bowel disease. Gut 1991;32:913-917.
93. Scharla SH, Stron DD, Mohan S, et al. Effect of tumour necrosis factor-alpha on the expression of insulin-like growth factor I and insulin-like growth factor binding protein 4 in mouse. Eur J Endocrinol 1994;131:293-301.
94. De Benedetti F, Alonzi T, Moretta A, et al. Interleukin 6 causes growth impairment in transgenic mice through a decrease in insulin-like growth factor-I. A model for stunted growth in children with chronic inflammation. J Clin Invest 1997;99:643-650.
95. Ballinger A. Fundamental mechanisms of growth failure in inflammatory bowel disease. Horm Res 2002;58(Suppl 1):7-10.
96. Fell JME, Paintin M, Arnaud-Battandier F, et al. Mucosal healing and a fall in mucosal pro-inflammatory cytokine mRNA induced by a specific oral polymeric diet in paediatric Crohn's disease. Aliment Pharmacol Ther 2000;14:281-289.
97. Bannerjee K, Camacho-Hübner C, Babinska K, et al. Anti-inflammatory and growth-stimulating effects precede nutritional restitution during enteral feeding in Crohn disease. J Pediatr Gastroenterol Nutr 2004; 38:270-277.
Was this article helpful?